Disphanurat, Wareeporn
Sivapornpan, Nakarin
Srisantithum, Benjaporn
Leelawattanachai, Jeerapond
Article History
Received: 9 November 2022
Revised: 9 November 2022
Accepted: 10 November 2022
First Online: 16 November 2022
Declarations
:
: The authors declare that they have no financial or non-financial competing interest.
: This prospective randomized, double-blind, split-scar controlled trial was approved by the Institutional Review Board of Thammasat University, Thailand (MTU-EC-IM-4-037/643). The study was conducted in accordance with good clinical practice guidelines and the 1975 Declaration of Helsinki.
: Written informed consent was obtained from all participants prior to treatment.